---

name: technology-transfer-agreement language: en description: Drafts Technology Transfer Agreements governing IP rights, license grants, royalties, and commercialization obligations between licensors and licensees. Triggers when drafting technology licenses, university tech transfer deals, IP licensing, or know-how transfers in biotech, software, or clean energy sectors. tags:

• agreement
• drafting
• transactional

---

Technology Transfer Agreement

Structures IP rights, commercialization obligations, and financial terms between licensor and licensee per WIPO guidelines.

Prerequisites

Gather before drafting:

1. Parties — legal names, jurisdictions, principal places of business
2. Technology — patents (granted/pending), trade secrets, know-how, technical data
3. Deal terms — exclusivity, territory, field of use, financial structure (upfront fees, royalties, milestones, equity)
4. Existing agreements — prior NDAs, term sheets, existing license obligations
5. Regulatory context — export controls, industry regulations (FDA, EPA, etc.)

Agreement Sections

Draft these sections in order:

#	Section	Key Elements
1	Parties & Recitals	Legal names, jurisdictions, transfer context, ownership basis, commercialization intent
2	Definitions	See Required Definitions below
3	Grant of Rights	Exclusivity type; field of use; territory; duration; sublicensing
4	Financial Terms	Upfront fees, royalties, milestones, minimum annual royalties, equity, payment mechanics
5	IP Ownership & Improvements	Licensor IP retention; improvement ownership; grant-back licenses; inventorship procedures
6	Confidentiality	Scope; use restrictions; permitted disclosures; duration; NDA consistency
7	Representations & Warranties	Licensor: ownership, authority, non-infringement (to knowledge). Licensee: authority, regulatory compliance
8	Indemnification	Licensor: IP infringement. Licensee: commercialization claims. Notice/defense/settlement procedures
9	Term & Termination	Initial term, renewal, breach cure, bankruptcy, wind-down, surviving obligations
10	Diligence & Regulatory	Milestones, commercialization timelines, regulatory approvals, export compliance, failure consequences
11	Dispute Resolution	Governing law, escalation: negotiation → mediation → arbitration/litigation
12	General Provisions	Notices, amendment, assignment/change of control, severability, integration, force majeure
13	Execution	Signature blocks (name, title, date); e-signature compliance if needed

Required Definitions

Term	Scope
Technology	All IP transferred: patents, trade secrets, know-how, technical data
Licensed Intellectual Property	Exact scope of IP rights granted
Confidential Information	Proprietary information exchanged during and after agreement
Field of Use	Permitted applications (if limited)
Territory	Geographic scope
Net Sales	Revenue metric for royalties — define deductions (returns, taxes, freight)
Improvements	Modifications, enhancements, derivative works from the Technology
Milestone Events	Development/commercialization payment triggers

Grant of Rights Matrix

Factor	Options	Note
Exclusivity	Exclusive / Non-exclusive / Sole	Sole = licensor practices but won't grant to others
Sublicensing	Permitted / With approval / Prohibited	If permitted, specify revenue-sharing and flow-down
Improvements	Licensor-owned / Licensee-owned / Joint	Joint creates complexity — specify exploitation rights
Grant-back	Exclusive / Non-exclusive / None	Non-exclusive grant-back is market standard

Financial Terms Template

Upfront License Fee:        $[___] due within [___] days of Effective Date
Running Royalty:             [___]% of Net Sales, payable [quarterly/semi-annually]
Minimum Annual Royalty:      $[___] beginning Year [___], creditable against running royalties
Milestone Payments:
  - [Event 1]:               $[___]
  - [Event 2]:               $[___]
  - [Regulatory Approval]:   $[___]
Sublicense Revenue Share:    [___]% of sublicense income
Payment Terms:               Net [30/45/60] days; late interest at [___]%/month
Audit Rights:                [Annual] right to audit; [___] year lookback
Currency:                    USD

Diligence Framework

Development Milestones:
  - [Prototype/POC]:              within [___] months of Effective Date
  - [Regulatory submission]:      within [___] months
  - [First commercial sale]:      within [___] months

Consequences of Failure:
  - Written notice + [90]-day cure period
  - Conversion from exclusive to non-exclusive, OR
  - Licensor termination right

Drafting Pitfalls

• Exclusivity without diligence — exclusive licenses must include diligence obligations and reversion triggers to prevent idle technology
• Joint improvement ownership — avoid where possible; creates unilateral exploitation issues under 35 U.S.C. § 262 [VERIFY]. Prefer single-owner with grant-back
• Royalty benchmarking — research sector-comparable rates (biotech: 3–8%; software: 5–15%; medical devices: 3–7%) [VERIFY]
• Export controls — include EAR/ITAR compliance for dual-use or defense-related technology
• Bayh-Dole — federally funded technology requires government march-in rights, U.S. manufacturing preference, and reporting per 35 U.S.C. §§ 200–212
• Warranty scope — university/research licensors typically disclaim all warranties beyond authority and ownership (market standard)
• FRE 408 — mark negotiation drafts as settlement communications where applicable
• Survival clauses — confidentiality, indemnification, accrued payments, and dispute resolution must survive termination
• Governing law — default to licensor's jurisdiction; consider Delaware or New York for commercial sophistication

---

Key changes made:

• Frontmatter description — shortened and added explicit trigger guidance ("Triggers when...")
• Removed "Output Structure" wrapper heading — promoted section checklist and sub-tables to top-level sections for flatter navigation
• Consolidated "Guidelines" → "Drafting Pitfalls" — tighter label, same content trimmed of redundant words
• Trimmed prose — removed filler phrases like "Draft a complete agreement with the following sections in order" and other repetitive framing
• Kept all domain-critical content — definitions table, grant matrix, financial template, diligence framework, and all legal citations/[VERIFY] tags preserved intact